New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Odisha received a major boost to its railway network on Saturday with the launch…
Bhubaneswar: With continuous rainfall pushing up the water level of the Baitarani River, the Odisha…
Puri: With preparations for the annual Rath Yatra entering the final phase, the Odisha Government…
Bhubaneswar: Urban infrastructure across Odisha is set for another major upgrade as the State Government…
Bhubaneswar: Odisha's rich handloom tradition took centre stage on Friday as the State Government organised…
Bhubaneswar: Odisha has achieved a significant milestone in wildlife science with the Centre for Wildlife…
